Cerebrolysin is a porcine brain-derived peptide mixture with over 30 years of clinical use, multiple Phase 3 randomized controlled trials, and Cochrane systematic review data for stroke and vascular dementia
Sakarya, Kirichenko, N., Morgan, D., Carter, C
Adapting Dosing During Acute Illnesses Acute illnesses, such as infections or hospitalizations, add extra strain to already compromised kidneys
From 1,309 bioactive molecules screened, the computer analysis selected GHK at 1 micromolar and securinine at 18 micromolar as the optimal agents capable of reversing expression of 54 gene sets overexpressed in malignant invasive colon cancer